1. Evidence-Based Follow-Up Schedules After Primary Cancer Treatment

   • Rachael L. Morton
   • John F. Thompson

   Melanoma 29 June 2020 Pages: 4067 - 4069

2. Adjuvant Transcatheter Arterial Infusion Therapy for Hepatocellular Carcinoma: Not Yet for Everybody

   • Kevin P. Labadie
   • Jonathan G. Sham

   Hepatobiliary Tumors 04 June 2020 Pages: 4070 - 4072

3. Diaphragmatic Involvement Should Not Preclude Curative-Intent Surgical Resection for Hepatocellular Carcinoma

   • Aslam Ejaz
   • Timothy M. Pawlik

   Hepatobiliary Tumors 23 June 2020 Pages: 4073 - 4074

4. Defining Early Multidisciplinary Goals: NEXTO Trial in High-Risk Colorectal Cancer with Liver Metastases

   • Jeremy D. Kratz
   • Noelle K. LoConte

   Hepatobiliary Tumors 22 May 2020 Pages: 4075 - 4078

   

5. Gastric Remnant Cancer: Is it different From Primary Gastric Cancer? Insights Into a Unique Clinical Entity

   • Mashaal Dhir

   Gastrointestinal Oncology 10 June 2020 Pages: 4079 - 4081

6. Radiomics for Diagnosing Lateral Pelvic Lymph Nodes in Rectal Cancer: Artificial Intelligence Enabling Precision Medicine?

   • Tarik Sammour
   • Sergei Bedrikovetski

   Colorectal Cancer 06 August 2020 Pages: 4082 - 4083

7. Editorial Comment on: DPP9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer

   • Takehiko Yokobori

   Colorectal Cancer 22 June 2020 Pages: 4084 - 4085

8. Electrochemotherapy for Pancreatic Cancer: An Emerging Treatment Modality?

   • Jin He

   Pancreatic Tumors 04 July 2020 Pages: 4086 - 4087

9. The Musician, Instrument, or Orchestra?

   • Todd L. Demmy

   Thoracic Oncology 08 July 2020 Pages: 4088 - 4090

10. A Potential Indication for Adjuvant Therapy in Node-Negative Esophageal Squamous Cell Carcinoma

    • Andrew M. Popoff

    Thoracic Oncology 20 July 2020 Pages: 4091 - 4092

11. Variation in Adequate Lymph Node Yield for Gastric, Lung, and Bladder Cancer: Attributable to the Surgeon, Pathologist, or Hospital?

    • Christopher T. Aquina
    • Matthew Truong
    • Adan Z. Becerra

    Health Services Research and Global Oncology 06 May 2020 Pages: 4093 - 4106

    

12. ASO Author Reflections: Variation in Adequate Lymph Node Yield: Current Status and Where Do We Go from Here?

    • Christopher T. Aquina
    • Adan Z. Becerra

    ASO Author Reflections 04 May 2020 Pages: 4107 - 4108

13. The MelFo Study UK: Effects of a Reduced-Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma 1B to 2C Patients After 3-Years

    • Marc D. Moncrieff
    • Beverly Underwood
    • Harald J. Hoekstra

    Melanoma Open access 04 July 2020 Pages: 4109 - 4119

    

14. ASO Author Reflections: The MelFo-Study, UK: Effects of a Reduced Frequency, Stage-Adjusted Follow-Up Schedule for Cutaneous Melanoma IB–IIC Patients After 3 Years

    • Marc Moncrieff
    • Beverly Underwood
    • Harald Hoekstra

    ASO Author Reflections Open access 10 July 2020 Pages: 4120 - 4121

15. Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

    • Lauren S. Levine
    • Kelly M. Mahuron
    • Adil I. Daud

    Melanoma 02 June 2020 Pages: 4122 - 4130

    

16. ASO Author Reflections: Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma

    • Kelly M. Mahuron
    • Lauren S. Levine
    • Adil I. Daud

    ASO Author Reflections 02 June 2020 Pages: 4131 - 4132

17. Sentinel Node Status is the Most Important Prognostic Information for Clinical Stage IIB and IIC Melanoma Patients

    • Isabela Bartelli Fonseca
    • Marcus Vitor Nunes Lindote
    • João Pedreira Duprat Neto

    Melanoma 07 August 2020 Pages: 4133 - 4140

    

18. ASO Author Reflections: Sentinel Node Biopsy—Retirement Will Have to Wait

    • Eduardo Bertolli
    • Vinicius Fernando Calsavara

    ASO Author Reflections 31 July 2020 Pages: 4141 - 4142

19. Is Postoperative Adjuvant Transcatheter Arterial Infusion Therapy Effective for Patients with Hepatocellular Carcinoma who Underwent Hepatectomy? A Prospective Randomized Controlled Trial

    • Fumitoshi Hirokawa
    • Koji Komeda
    • Kazuhisa Uchiyama

    Hepatobiliary Tumors 04 June 2020 Pages: 4143 - 4152

    

20. Hepatectomy Combined with Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement: A Propensity Score-Matched Analysis

    • Tatsuya Orimo
    • Toshiya Kamiyama
    • Akinobu Taketomi

    Hepatobiliary Tumors 25 June 2020 Pages: 4153 - 4163

    

21. ASO Author Reflections: Is Hepatectomy Plus Diaphragmatic Resection for Hepatocellular Carcinoma with Diaphragmatic Involvement Justified?

    • Tatsuya Orimo
    • Toshiya Kamiyama
    • Akinobu Taketomi

    ASO Author Reflections 23 June 2020 Pages: 4164 - 4165

22. Robotic Resection of Hilar Cholangiocarcinoma

    • Marcel Autran Machado
    • Bruno V. Mattos
    • Fabio Makdissi

    Hepatobiliary Tumors 03 May 2020 Pages: 4166 - 4170

    

23. Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas

    • Yoshitsugu Nakanishi
    • Keisuke Okamura
    • Satoshi Hirano

    Hepatobiliary Tumors 03 May 2020 Pages: 4171 - 4180

    

24. Laparoscopic Caudate Lobectomy for Cholangiocarcinoma of Caudate Lobe Invading Middle Hepatic Vein

    • Hai-Feng Wan
    • Kun-Lin Xie
    • Ji-Wei Huang

    Hepatobiliary Tumors 16 May 2020 Pages: 4181 - 4185

    

25. ASO Author Reflections: Laparoscopic Caudate Lobectomy: A Feasible and Safe Approach for Cholangiocarcinoma of the Caudate Lobe Invading the Middle Hepatic Vein

    • Guo-Teng Qiu
    • Kun-Lin Xie
    • Ji-Wei Huang

    ASO Author Reflections 18 May 2020 Pages: 4186 - 4187

26. A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial)

    • Yoshihiro Mise
    • Kiyoshi Hasegawa
    • Norihiro Kokudo

    Gastrointestinal Oncology 08 June 2020 Pages: 4188 - 4195

    

27. Surgery for Gastric Remnant Cancer Results in Similar Overall Survival Rates Compared with Primary Gastric Cancer: A Propensity Score-Matched Analysis

    • Christian Galata
    • Ulrich Ronellenfitsch
    • Julia Hardt

    Gastrointestinal Oncology Open access 02 June 2020 Pages: 4196 - 4203

    

28. Occult Tumour Cells in Lymph Nodes from Gastric Cancer Patients: Should Isolated Tumour Cells Also Be Considered?

    • A. Tavares
    • X. Wen
    • M. Dinis-Ribeiro

    Gastrointestinal Oncology 04 May 2020 Pages: 4204 - 4215

    

29. Surveillance Endoscopy Guidelines for Postgastrectomy Patients Based on Risk of Developing Remnant Gastric Cancer

    • Eui Soo Han
    • Ho Seok Seo
    • Han Hong Lee

    Gastrointestinal Oncology 05 May 2020 Pages: 4216 - 4224

    

30. Impact of Extracapsular Extension of Lymph Node in Adenocarcinoma of the Stomach

    • Bofei Li
    • Ian Yu-Hong Wong
    • Simon Law

    Gastrointestinal Oncology 05 May 2020 Pages: 4225 - 4232

    

31. ASO Author Reflections: Extracapsular Extension of Lymph Node: An Important Consideration for Gastric Cancer

    • Bofei Li
    • Anthony W. I. Lo
    • Simon Law

    ASO Author Reflections 07 May 2020 Pages: 4233 - 4234

32. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer

    • Kazuki Kano
    • Takanobu Yamada
    • Takashi Oshima

    Gastrointestinal Oncology 18 May 2020 Pages: 4235 - 4247

    

33. ASO Author Reflections: Association Between the Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer

    • Kazuki Kano
    • Takanobu Yamada
    • Takashi Oshima

    ASO Author Reflections 27 May 2020 Pages: 4248 - 4249

34. Surgical Outcome and Long-Term Survival of Conversion Surgery for Advanced Gastric Cancer

    • Guo-Ming Chen
    • Shu-Qiang Yuan
    • Ying-Bo Chen

    Gastrointestinal Oncology 06 June 2020 Pages: 4250 - 4260

    

35. ASO Author Reflection: Tending Towards a Personalized Treatment for Advanced Gastric Cancer Patients by Adding the Conversion Surgery

    • Guo-Ming Chen
    • Run-Cong Nie
    • Ying-Bo Chen

    ASO Author Reflections 13 May 2020 Pages: 4261 - 4262

36. The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis

    • Yoshikuni Kawaguchi
    • Jean-Nicolas Vauthey

    Colorectal Cancer 14 August 2020 Pages: 4263 - 4270

    

37. ASO Author Reflections: The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis

    • Yoshikuni Kawaguchi
    • Jean-Nicolas Vauthey

    ASO Author Reflections 08 July 2020 Pages: 4271 - 4272

38. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer

    • Ryota Nakanishi
    • Takashi Akiyoshi
    • Hiroya Kuroyanagi

    Colorectal Cancer 07 August 2020 Pages: 4273 - 4283

    

39. ASO Author Reflections: CT-Based Radiomics Model to Predict Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer

    • Ryota Nakanishi
    • Takashi Akiyoshi

    ASO Author Reflections 01 August 2020 Pages: 4284 - 4285

40. Surgical Management and Outcomes of Rectal Cancer with Synchronous Prostate Cancer: A Multicenter Experience from the GRECCAR Group

    • Alexandre Doussot
    • Dewi Vernerey
    • French Research Group of Rectal Cancer Surgery (GRECCAR)

    Colorectal Cancer 04 June 2020 Pages: 4286 - 4293

    

41. ASO Author Reflections: Challenges in the Management of Synchronous Prostate Cancer and Rectal Cancer: Towards Double Organ Preservation?

    • Alexandre Doussot
    • Zaher Lakkis

    ASO Author Reflections 29 May 2020 Pages: 4294 - 4295

42. Multiparametric MRI and Whole Slide Image-Based Pretreatment Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Multicenter Radiopathomic Study

    • Lizhi Shao
    • Zhenyu Liu
    • Jie Tian

    Colorectal Cancer Open access 29 July 2020 Pages: 4296 - 4306

    

43. ASO Author Reflections: Radiopathomics Strategy of Combing Multi-scale Tumor Information on Pretreatment to Predict the Pathologic Response to Neoadjuvant Therapy

    • Jie Tian
    • Xinjuan Fan
    • Guanyu Yang

    ASO Author Reflections Open access 03 June 2020 Pages: 4307 - 4308

44. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer

    • Wen-Shih Huang
    • Feng-Che Kuan
    • Wen-Cheng Chen

    Colorectal Cancer 13 August 2020 Pages: 4309 - 4318

    

45. Pathological Complete Response Following Different Neoadjuvant Treatment Strategies for Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis

    • S. Hoendervangers
    • J. P. M. Burbach
    • H. M. Verkooijen

    Colorectal Cancer Open access 10 June 2020 Pages: 4319 - 4336

    

46. Dipeptidyl Peptidase 9 Increases Chemoresistance and is an Indicator of Poor Prognosis in Colorectal Cancer

    • Kazuhiro Saso
    • Norikatsu Miyoshi
    • Hidetoshi Eguchi

    Translational Research and Biomarkers 30 July 2020 Pages: 4337 - 4347

    

47. Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma

    • Neal Bhutiani
    • Yan Li
    • Robert C. G. Martin II

    Translational Research 17 July 2020 Pages: 4348 - 4359

    

48. High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer

    • Seded Baatar
    • Tuya Bai
    • Hiroshi Saeki

    Translational Research and Biomarkers 30 April 2020 Pages: 4360 - 4368

    

49. ASO Author Reflections: High RAD18 Expression is Associated with Disease Progression and Poor Prognosis for Patients with Gastric Cancer

    • Takehiko Yokobori
    • Navchaa Gombodorj
    • Hiroshi Saeki

    ASO Author Reflections 08 May 2020 Pages: 4369 - 4370

50. Perineural Invasion is a Better Prognostic Indicator than Lymphovascular Invasion and a Potential Adjuvant Therapy Indicator for pN0M0 Esophageal Squamous Cell Carcinoma

    • Yuan-ning Guo
    • Dong-ping Tian
    • Min Su

    Thoracic Oncology 09 June 2020 Pages: 4371 - 4381